Bioengineering and Translational Medicine for the Advancement of Healthcare

The latest news

AACR Cancer Research, MD Anderson Cancer Center

Cancer researchers at the MD Anderson Cancer Center use Redoxica's 2-Cys-Peroxiredoxin Activity Assay technology to determine that SIRT2 deacetylates and inhibits the peroxidase activity of peroxiredoxin-1 to sensitize breast cancer cells to oxidant stress-inducing agents.